ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,000 | -40.6% | 9,300 | -33.5% | 0.04% | -25.5% |
| Q2 2023 | $401,000 | +19.7% | 13,975 | 0.0% | 0.05% | +11.9% |
| Q1 2023 | $335,000 | -84.0% | 13,975 | -68.1% | 0.04% | -87.7% |
| Q3 2021 | $2,093,000 | +5.2% | 43,800 | -25.5% | 0.34% | +15.6% |
| Q2 2021 | $1,990,000 | +140.9% | 58,800 | +194.0% | 0.30% | +109.2% |
| Q1 2021 | $826,000 | – | 20,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |